Screener
LABD vs HIBL
Direxion Daily S&P Biotech Bear 3X Shares vs Direxion Daily S&P 500 High Beta Bull 3X Shares
Key differences
- HIBL costs 0.09% less per year.
- LABD follows a inverse strategy; HIBL uses leveraged.
- Over the last 3 years, HIBL has delivered higher annualized returns.
Side-by-side comparison
| LABD | HIBL | |
|---|---|---|
| Annual cost (TER) | 1.07% | 0.98% |
| Fund size (AUM) | $69M | $83M |
| Since | 2015 | 2019 |
| Dividend yield | 6.38% | 1.66% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | inverse | leveraged |
| CAGR 1Y | -82.9% | +242.4% |
| CAGR 3Y | -50.8% | +60.5% |
| CAGR 5Y | -42.0% | +8.7% |
| Sharpe 3Y | -0.52 | 0.96 |
| Volatility 1Y | 74.72% | 66.14% |
| Max drawdown | -99.98% | -88.27% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to LABD and HIBL
Explore further